Originally published October 11 2005
GlaxoSmithKline faces public criticism for manipulating drug trial results
by Mike Adams, the Health Ranger, NaturalNews Editor
An American consumer group believes the drug manufacturer GSK changed the results of a 26,000-patient study of Serevent, its asthma treatment drug.
GlaxoSmithKline, the UK's biggest pharmaceuticals group, is this morning facing new allegations that it withheld important safety data on one of its most important drugs.
An American consumer campaign group claims GSK manipulated results of a 26,000-patient study of its asthma treatment Serevent, which is known as Advair when in combination with another drug.
All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing LLC takes sole responsibility for all content. Truth Publishing sells no hard products and earns no money from the recommendation of products. NaturalNews.com is presented for educational and commentary purposes only and should not be construed as professional advice from any licensed practitioner. Truth Publishing assumes no responsibility for the use or misuse of this material. For the full terms of usage of this material, visit www.NaturalNews.com/terms.shtml